Effects of the novel immunosuppressant brequinar on hepatic UDP-glucuronic acid levels and UDP-glucuronyltransferase activities in the rat.
Diamond
S
S
DuPont Merck Pharmaceutical Company, Stine-Haskell Research Center, Newark, DE 19714, USA.
Christ
D D
DD
D000818:Animals; D001713:Biphenyl Compounds / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D014453:Glucuronosyltransferase / Q000378:metabolism*; D007166:Immunosuppressive Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D014535:Uridine Diphosphate Glucuronic Acid / Q000378:metabolism*; D011798:Quinaldines
D001713:Biphenyl Compounds; D014453:Glucuronosyltransferase; D007166:Immunosuppressive Agents; D014535:Uridine Diphosphate Glucuronic Acid; C046943:brequinar; D011798:Quinaldines